Ascendis Pharma Ownership | Who Owns Ascendis Pharma?

Ascendis Pharma Ownership Summary

Ascendis Pharma is owned by 108.48% institutional investors, 0.78% insiders. T. rowe price investment management is the largest institutional shareholder, holding 10.95% of ASND shares. T. Rowe Price Capital Appreciation is the top mutual fund, with 4.46% of its assets in Ascendis Pharma shares.

ASND Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ascendis Pharma	108.48%	0.78%	-9.26%
Sector	Healthcare Stocks	50.44%	12.38%	37.18%
Industry	Biotech Stocks	48.97%	12.07%	38.96%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
T. rowe price investment management	6.75M	10.95%	$1.80B
Lombard odier asset management (europe)	4.27M	7.06%	$5.83M
Price t rowe associates inc /md/	1.12M	1.82%	$299.40M
State street	513.97K	0.83%	$137.09M
Blackrock	405.99K	0.71%	$55.37M
Groupama asset managment	400.00K	0.67%	$505.75K
Ameriprise financial	320.51K	0.52%	$85.49M
Two sigma investments, lp	305.80K	0.50%	$81.56M
Camber capital management lp	250.00K	0.42%	$43.15M
Frazier life sciences management	225.16K	0.36%	$60.05M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Q global advisors	100.00K	17.01%	$26.67M
Ally bridge group (ny)	51.08K	6.18%	$10.16M
Great point partners	75.00K	6.15%	$14.91M
Camber capital management lp	250.00K	4.05%	$43.15M
Ghost tree capital	86.72K	3.70%	$11.83M
Evolutionary tree capital management	6.05K	3.04%	$1.61M
Acuta capital partners	9.79K	2.01%	$1.95M
Oddo bhf asset management sas	128.66K	1.59%	$34.32M
Frazier life sciences management	225.16K	1.31%	$60.05M
T. rowe price investment management	6.75M	1.18%	$1.80B

Top Buyers

Holder	Shares	% Assets	Change
Lombard odier asset management (europe)	4.27M	0.29%	4.27M
T. rowe price investment management	6.75M	1.18%	592.80K
State street	513.97K	0.00%	426.63K
Ameriprise financial	320.51K	0.02%	320.51K
Two sigma investments, lp	305.80K	0.06%	305.80K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-10.28M
Avoro capital advisors	-	-	-5.06M
Westfield capital management co lp	-	-	-4.81M
Janus henderson group	-	-	-4.06M
Fmr	-	-	-3.88M

New Positions

Holder	Shares	% Assets	Change	Value
Lombard odier asset management (europe)	4.27M	0.29%	4.27M	$5.83M
Ameriprise financial	320.51K	0.02%	320.51K	$85.49M
Two sigma investments, lp	305.80K	0.06%	305.80K	$81.56M
Jane street group	187.14K	0.00%	187.14K	$49.91M
Neuberger berman group	142.71K	0.03%	142.71K	$38.06M

Sold Out

Holder	Change
Dv trading	-1.00
Northwestern mutual wealth management	-1.00
Rakuten securities	-1.00
Kilter group	-1.00
Td private client wealth	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	331	14.14%	66,912,690	22.30%	108	1.38%	192	32.41%	94	-9.62%
Mar 31, 2026	289	-11.62%	54,713,210	-15.41%	89	0.79%	147	-18.78%	101	5.21%
Dec 31, 2025	209	-31.25%	22,626,743	-66.96%	37	0.29%	122	-26.06%	53	-43.62%
Sep 30, 2025	291	15.48%	67,939,274	10.42%	112	1.07%	162	26.56%	88	4.76%
Jun 30, 2025	259	1.57%	63,281,991	-3.50%	105	0.88%	128	-0.78%	87	-2.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Capital Appreciation	2.74M	4.46%	2.74M
MFS Mid Cap Growth Equity	1.27M	2.06%	-5.90K
MFS Mid Cap Growth A	1.27M	2.06%	-5.90K
Capital Group Growth Fnd of Amer Comp	1.21M	1.97%	-
American Funds Growth Fund of Amer A	1.21M	1.97%	-
Franklin Innovation Composite	1.10M	1.79%	100.00K
Franklin DynaTech A	1.10M	1.79%	100.00K
Vanguard Health Care Inv	1.10M	1.79%	-
Franklin DynaTech Fund A	1.00M	1.63%	-
Janus Henderson Mid Cap Growth MA	976.88K	1.59%	976.88K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 14, 2026	BIENAIME JEAN JACQUES	-	Buy	$270.44K
Aug 14, 2026	BIENAIME JEAN JACQUES	-	Buy	$222.22K
Jun 02, 2026	SMITH SCOTT THOMAS	EVP & Chief Financial Officer	Buy	$21.90K
May 29, 2026	BIENAIME JEAN JACQUES	-	Buy	$44.75K
May 29, 2026	BIENAIME JEAN JACQUES	-	Buy	$22.35K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	7	1
2026 Q1	-	-

ASND Ownership FAQ

Who Owns Ascendis Pharma?

Ascendis Pharma shareholders are primarily institutional investors at 108.48%, followed by 0.78% insiders and -9.26% retail investors. The average institutional ownership in Ascendis Pharma's industry, Biotech Stocks , is 48.97%, which Ascendis Pharma exceeds.

Who owns the most shares of Ascendis Pharma?

Ascendis Pharma’s largest shareholders are T. rowe price investment management (6.75M shares, 10.95%), Lombard odier asset management (europe) (4.27M shares, 7.06%), and Price t rowe associates inc /md/ (1.12M shares, 1.82%). Together, they hold 19.83% of Ascendis Pharma’s total shares outstanding.

Does Blackrock own Ascendis Pharma?

Yes, BlackRock owns 0.71% of Ascendis Pharma, totaling 405.99K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 55.37M$. In the last quarter, BlackRock increased its holdings by 820 shares, a 0.20% change.

Who is Ascendis Pharma’s biggest shareholder by percentage of total assets invested?

Q global advisors is Ascendis Pharma’s biggest shareholder by percentage of total assets invested, with 17.01% of its assets in 100K Ascendis Pharma shares, valued at 26.67M$.

Who is the top mutual fund holder of Ascendis Pharma shares?

T. Rowe Price Capital Appreciation is the top mutual fund holder of Ascendis Pharma shares, with 4.46% of its total shares outstanding invested in 2.74M Ascendis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools